UNIVERSITY OF NORTH CAROLINA HOSPITALS

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1989-01-01

Employees: -

Market Cap: -

Website: http://www.unc.edu/interactive-tour/unc-hospitals/

Clinical Trials

Retinal Oxygen Function After Radiation Therapy

Completed

Conditions: A History of Radiation Therapy for a Tumor in the Vicinity of the Retina(s)

First Posted Date: 2014-01-23

Last Posted Date: 2019-08-28

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 32

Registration Number: NCT02043470

Locations: 🇺🇸
Department of Radiation Oncology Clinic, Chapel Hill, North Carolina, United States

Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients

Phase 2

Completed

Conditions: Endometrial Cancer
Complex Atypical Hyperplasia

Interventions: Drug: Metformin

First Posted Date: 2014-01-14

Last Posted Date: 2024-12-18

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 20

Registration Number: NCT02035787

Locations: 🇺🇸
Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States
🇺🇸
TriHealth, Cincinnati, Ohio, United States

The Use of Smart Scales for Weight Gain Prevention in African American Breast Cancer Survivors

Not Applicable

Completed

Conditions: Body Weight Changes
Breast Neoplasms

Interventions: Behavioral: Self-regulation
Behavioral: Self-regulation plus activity monitoring

First Posted Date: 2014-01-08

Last Posted Date: 2016-01-20

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 35

Registration Number: NCT02030353

Locations: 🇺🇸
University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States

Neoadjuvant Chemoradiotherapy With CRLX-101 and Capecitabine for Rectal Cancer

Phase 1

Terminated

Conditions: Rectal Cancer

Interventions: Drug: CRLX101
Drug: Capecitabine
Radiation: Radiotherapy
Procedure: Surgery

First Posted Date: 2013-12-12

Last Posted Date: 2020-11-03

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 32

Registration Number: NCT02010567

Locations: 🇺🇸
University of North Carolina, Chapel Hill, North Carolina, United States
🇺🇸
Rocky Mountain Cancer Center, Denver, Colorado, United States
🇺🇸
Indiana University Simon Cancer Center, Indianapolis, Indiana, United States

and more 3 locations

Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer

Completed

Conditions: Metastatic Castrate-Resistant Prostate Cancer

Interventions: Behavioral: Survey

First Posted Date: 2013-12-11

Last Posted Date: 2020-03-30

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 213

Registration Number: NCT02008058

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸
Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States
🇺🇸
University of Washington, Seattle, Washington, United States

and more 1 locations

Cardiovascular Risk and Preventive Care in Prostate Cancer Patients Receiving Radiation and Hormone Therapy

Completed

Conditions: Prostate Cancer

First Posted Date: 2013-12-06

Last Posted Date: 2018-08-14

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 101

Registration Number: NCT02003417

Locations: 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
🇺🇸
Medstar Georgetown University Hospital, Washington, District of Columbia, United States
🇺🇸
Rex Healthcare of Wakefield, Raleigh, North Carolina, United States

and more 5 locations

Pilot Study: Utilizing Manometry to Assess Radiation-Induced Changes in Esophageal Function

Terminated

Conditions: Lung Cancer

First Posted Date: 2013-11-25

Last Posted Date: 2017-04-06

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 5

Registration Number: NCT01992068

Locations: 🇺🇸
Department of Radiation Oncology Clinic, Chapel Hill, North Carolina, United States

Single Subject Neratinib in Bladder Cancer (NRR)

Conditions: Bladder Cancer

First Posted Date: 2013-10-08

Last Posted Date: 2017-03-14

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Registration Number: NCT01956253

Locations: 🇺🇸
North Carolina Cancer Hospital (UNC), Chapel Hill, North Carolina, United States

Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib

Early Phase 1

Completed

Conditions: Breast Neoplasms

Interventions: Drug: pertuzumab
Drug: Trastuzumab
Drug: lapatinib

First Posted Date: 2013-06-12

Last Posted Date: 2020-09-04

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 26

Registration Number: NCT01875666

Locations: 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
MD Anderson, Houston, Texas, United States

and more 2 locations

Effect of Curcumin on Dose Limiting Toxicity and Pharmacokinetics of Irinotecan in Patients With Solid Tumors

Phase 1

Completed

Conditions: Advanced Colorectal Cancer

Interventions: Dietary Supplement: curcumin
Drug: Irinotecan

First Posted Date: 2013-05-22

Last Posted Date: 2023-12-04

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 23

Registration Number: NCT01859858

Locations: 🇺🇸
IU Simon Cancer Center, Indianapolis, Indiana, United States
🇺🇸
University of North Carolina at Chapel Hill Lineberger Comprehensive cancer Center, Chapel Hill, North Carolina, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy